This lecture is part of the CBR seminar series.
Extensive transfusion support often fails to prevent death from bleeding after trauma. Early intervention may improve outcomes, but which blood products, factor concentrates, or other drugs are the best treatment is unclear. Patients with acute traumatic coagulopathy (ATC), arising from trauma and hemorrhagic shock, have the worst prognosis. This lecture will describe research that adapted a mouse model of ATC to determine if hemostatic control had been restored by different resuscitation fluids.
Dr. William Sheffield
Professor, Department of Pathology and Molecular Medicine, McMaster University
Associate Director (Research) and Senior Scientist, Canadian Blood Services
For information about CBR Seminar series events and to receive Zoom access information, visit the CBR website: CBR Seminars | Centre for Blood Research (ubc.ca)